Gut microbiota and epilepsy: how the gut can modulate the seizure threshold

The gut–brain axis

Over the past decade, neuroscience has shown that the gut microbiota communicates with the brain in both directions, along what we now call the "gut–brain axis." It is a complex, still only partly understood communication network involving the vagus nerve and the enteric nervous system, hormones, immune molecules such as cytokines and chemokines, and neurotransmitters. When the composition of the microbiota is altered — a condition known as dysbiosis — this imbalance has been linked to several disorders of the central nervous system, including multiple sclerosis, Parkinson's disease, and Alzheimer's disease.

The research question

Some studies had reported significant differences in the gut microbiota of people with epilepsy compared with healthy volunteers. One crucial question remained open, however: is the altered microbiota merely a consequence of the disease, or can it actively help lower the seizure threshold? In other words, can an "epileptic" microbiota, on its own, make a healthy brain more excitable?

The experiment

To find out, the group used fecal microbiota transplantation (FMT): microbiota from donor mice made epileptic was transferred to young, healthy recipient mice with a still-immature microbiota. After the transplant, all recipients were given a "subclinical" dose of pilocarpine — an amount not in itself enough to trigger a seizure — to test whether the transferred microbiota had lowered the brain's excitability threshold.

The results

Even at baseline, the mice that had received the "epileptic" microbiota (the R-EPI group) showed a higher number of EEG "spikes" than the controls (the R-CTL group): a first sign of greater excitability. The clearest difference came after the subclinical dose of pilocarpine: about half of the R-EPI mice — 10 out of 21 — developed status epilepticus, compared with just one animal out of 13 in the control group.

The "double-hit" hypothesis

These findings fit the so-called "double-hit" hypothesis: an insult that is not enough on its own to cause epilepsy can trigger a cascade of epileptogenic events when combined, over time, with a second stimulus. According to the authors, the microbiota alterations caused by epilepsy represent the first "hit" in the recipient mice; the subclinical dose of pilocarpine is the second. The transplant alone did not cause seizures in the following three weeks; but it made the same animals far more likely to develop status epilepticus after the second stimulus. Pilocarpine, after all, acts on inflammatory pathways — much like conditions such as fever and influenza, which are sometimes associated with the onset of seizures in already-sensitised individuals.

For the first time, microbiota from epileptic donors was shown to lower the seizure threshold in healthy recipients.

What it means

The work provides the first evidence that microbiota transferred from epileptic donors can lower the seizure threshold in healthy recipients, supporting the idea that the microbiota, through the gut–brain axis, can influence the brain's excitability. It is a perspective that opens the way to integrative therapeutic approaches — probiotics, prebiotics, FMT itself, and nutrition-based strategies targeting the gut–brain axis. Fittingly, the anti-seizure effect of the ketogenic diet, long known in some forms of drug-resistant epilepsy, is now also being traced back to the gut microbiota. Understanding which microbiota alterations truly matter, and by which molecular mechanisms they act along the microbiota–gut–brain axis, remains the next challenge.